Press "Enter" to skip to content

ICICI Direct Issues Buy Recommendation for PPL Pharma

By bigbreakingwire on September 30, 2024

Table of Contents

ICICI Direct has set a target price of Rs 280 for PPL Pharma, up from the current price of Rs 226.31, indicating a potential upside of 23.72%.

Published in Brokerage Reports

bigbreakingwire
bigbreakingwire

Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.

More from Brokerage ReportsMore posts in Brokerage Reports »

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *